Homocysteine, Serum
Homocysteine (HCY) is a sulfur-containing amino acid produced during catabolism of methionine, an essential amino acid. There are two major pathways for synthesis of HCY in our body: remethylation and transsulfuration pathway. The remethylation pathway is catalyzed by the enzymes methylenetetrahydrofolate reductase (MTHFR) and methionine synthase, a process requiring vitamin B12, folic acid, and riboflavin. In transsulfuration pathway, HCY is converted to cysteine and glutathione, a process requiring vitamin B6 and riboflavin. Folic acid and vitamin B12 function as cofactors and substrates in both pathways. If one or more of the HCY metabolic pathways are inhibited due to enzymatic defects or vitamin deficiencies, HCY accumulates, causing an increased HCY level in plasma. Deficiencies in one or more of these vitamins can lead to acquired hyperhomocysteinemia. Homocystinuria is a rare autosomal recessive disorder caused by mutation and decreased activity of cystathionine synthase. Clinical and epidemiologic studies have demonstrated that hyperhomocysteinemia is an independent risk factor for atherosclerosis and coronary heart disease and for arterial and venous thromboembolism.
Homocysteine is present in plasma in three forms: free or unbound HCY (1 to 2%), homocysteine-cysteine or homocysteine dimers (10 to 20%), or protein bound (> 80%). Total plasma homocysteine, free and bound, is commonly referred to as either homocysteine or homocyst(e)ine. There are some assays that can measure free or unbound homocysteine but most assays measure total homocysteine level.
- Evaluation of risk factors associated with atherosclerosis, coronary heart disease, and arterial/venous thromboembolism
- Aids in the evaluation of B6, B12, Folic Acid, and Riboflavin deficiency
- As an aid in diagnosis of arterial thrombosis and venous thrombosis
- As an aid in diagnosis of neural tube defect (related to folate deficiency)
- As an aid in diagnosis of pregnancy complications such as preeclampsia and recurrent miscarriages
Increased in:
- Homocystinuria due to reduced function in cystathionine synthase, and/or methionine synthase
- MTHFR C677T and A1298C mutation
- Deficiency of B6, B12, Folic Acid, or Riboflavin
- Chronic alcohol ingestion
- Renal failure
- Systemic lupus erythematosus
- Hypothyroidism
- Diabetes mellitus
- Use of certain medications such as methotrexate and nicotinic acid
Decreased in:
- Down syndrome
- Hyperthyroidism
Male: 4 – 12 µmol/L
Female: 4 – 10 µmol/L
Serum (SST) or Plasma EDTA (Lavender),Heparin (Green).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- PLoS One. 2010 Feb 9;5(2):e9136. [PMID: 20161734]
- Crit Rev Clin Lab Sci. 1999 Aug;36(4):365-406. [PMID: 10486705]
- Circulation. 1999;99:178. [PMID: 9884399]
- Public Health Nutr. 2001 Apr;4(2B):493-7. [PMID: 11683544]
- J Am Acad Nurse Pract. 2005;17:90. [PMID: 15748221]
- Clin Chem. 2007;53:807. [PMID: 17468406]
- Semin Hematol. 2007;44:62. [PMID: 17433897]
- Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson,OH. Lexi-Comp, Inc (2001).